Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    2(67%)

    Phase Distribution

    Early Phase 1
    1
    33%
    Phase 1
    2
    67%

    Phase Distribution

    3

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Early Phase 1First-in-human
    1(33.3%)
    Phase 1Safety & dosage
    2(66.7%)

    Highest Phase Reached

    Phase 1

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 1 finished

    Non-Completion Rate

    100.0%

    1 ended early

    Currently Active

    2

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Active(2)
    Terminated(1)

    Detailed Status

    Recruiting2
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    2
    Success Rate
    N/A
    Most Advanced
    Early Phase 1

    Trials by Phase

    Early Phase 11 (33.3%)
    Phase 12 (66.7%)

    Trials by Status

    withdrawn133%
    recruiting267%

    Recent Activity

    2 active trials
    Showing 3 of 3
    recruitingphase_1

    Drug Screening Using Novel IMD in Renal Cell Carcinoma

    NCT05700461
    recruitingearly_phase_1

    Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers

    NCT05553782
    withdrawnphase_1

    Implantable Microdevice for TNBC - Pilot Study

    NCT05774886

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT05700461Phase 1

    Drug Screening Using Novel IMD in Renal Cell Carcinoma

    Recruiting
    NCT05553782Early Phase 1

    Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers

    Recruiting
    NCT05774886Phase 1

    Implantable Microdevice for TNBC - Pilot Study

    Withdrawn

    All 3 trials loaded

    Drug Details

    Intervention Type
    Combination product
    Total Trials
    3